Selectivity of class-III antiarrhythmic action of clofilium in guinea pig ventricular myocytes

被引:15
|
作者
Li, Q [1 ]
Himmel, HM [1 ]
Ravens, U [1 ]
机构
[1] UNIV ESSEN GESAMTHSCH,INST PHARMAKOL,D-45122 ESSEN,GERMANY
关键词
clofilium; class-II antiarrhythmic action; selectivity; guinea pig ventricular myocytes; delayed rectifier current; inward rectifier current; calcium current; sodium current;
D O I
10.1097/00005344-199603000-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clofilium is an antiarrhythmic agent with a supposedly predominant class-III action which is related to impairment of K+ channel function. We investigated membrane currents in cardiac myocytes isolated from guinea pig ventricle to evaluate the selectivity of action of clofilium on K+ currents. For measurement of action potentials or membrane currents, the single electrode patch clamp technique was applied in current- or voltage-clamp mode, respectively. Clofilium (30 mu M) irreversibly prolonged the action potential duration in guinea pig myocytes. In contrast, the concomitant reduction in plateau phase was completely reversible. The delayed rectifier K+ current I-K was reduced. The rapidly activating component of I-K which has been defined by its sensitivity to the compound E-4031, was also reduced by clofilium. The inward rectifier was slightly inhibited by the drug. Clofilium reversibly reduced L-type Ca2+ current. Sodium current was inhibited in a use-dependent manner. This effect was not reversible but proceeded after washout of the compound. Therefore, clofilium affects both inward and outward currents in mammalian cardiac myocytes in a similar concentration range. The effects on multiple membrane currents may contribute to the antiarrhythmic action of the drug.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [31] Antiarrhythmic effects of magnesium on rat papillary muscle and guinea pig ventricular myocytes
    Aomine, M
    Tatsukawa, Y
    Yamato, T
    Yamasaki, S
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1999, 32 (01): : 107 - 114
  • [32] EFFECT OF AMBASILIDE, A NEW CLASS-III AGENT, ON PLATEAU CURRENTS IN ISOLATED GUINEA-PIG VENTRICULAR MYOCYTES - BLOCK OF DELAYED OUTWARD POTASSIUM CURRENT
    ZHANG, ZH
    FOLLMER, CH
    SARMA, JSM
    CHEN, FH
    SINGH, BN
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 263 (01): : 40 - 48
  • [33] SOTALOL - A UNIQUE CLASS-III ANTIARRHYTHMIC AGENT
    BARLOW, JB
    OBEL, IWP
    POCOCK, WA
    MCKIBBIN, JK
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (12): : 932 - 933
  • [34] SOTALOL - A NEW CLASS-III ANTIARRHYTHMIC AGENT
    ZANETTI, LAF
    CLINICAL PHARMACY, 1993, 12 (12): : 883 - 891
  • [35] CLASS-III ANTIARRHYTHMIC ACTION IN EXPERIMENTAL ATRIAL-FIBRILLATION AND FLUTTER IN DOGS
    PLATOU, ES
    REFSUM, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (05) : 839 - 846
  • [36] PROARRHYTHMIC EFFECTS OF CLASS-III ANTIARRHYTHMIC AGENTS
    REES, S
    CARDIOVASCULAR RESEARCH, 1993, 27 (12) : 2285 - 2286
  • [37] IS IT PRACTICAL TO DEVELOP A CLASS-III ANTIARRHYTHMIC AGENT
    AGERSBORG, HPK
    LATTS, J
    RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 157 - 166
  • [38] EFFECTS OF ELEVATED EXTRACELLULAR POTASSIUM CONCENTRATIONS ON THE CLASS-III ANTIARRHYTHMIC ACTION OF SOTALOL
    COBBE, SM
    MANLEY, BS
    CARDIOVASCULAR RESEARCH, 1985, 19 (02) : 69 - 75
  • [39] DOFETILIDE, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT
    RASMUSSEN, HS
    ALLEN, MJ
    BLACKBURN, KJ
    BUTROUS, GS
    DALRYMPLE, HW
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S96 - S105
  • [40] VASCULAR EFFECTS OF CLASS-III ANTIARRHYTHMIC AGENTS
    BASKIN, E
    SERIK, C
    WALLACE, A
    JURKIEWICZ, N
    WINQUIST, R
    LYNCH, J
    DRUG DEVELOPMENT RESEARCH, 1992, 26 (04) : 481 - 488